Relationship Between Adherence to Remote Monitoring and Patient Characteristics: Observational Study in Women With Pregnancy-Induced Hypertension

Thijs Vandenberk, Dorien Lanssens, Valerie Storms, Inge M Thijs, Lotte Bamelis, Lars Grieten, Wilfried Gyselaers, Eileen Tang, Patrick Luyten, Thijs Vandenberk, Dorien Lanssens, Valerie Storms, Inge M Thijs, Lotte Bamelis, Lars Grieten, Wilfried Gyselaers, Eileen Tang, Patrick Luyten

Abstract

Background: Pregnancy-induced hypertension (PIH) is associated with high levels of morbidity and mortality in mothers, fetuses, and newborns. New technologies, such as remote monitoring (RM), were introduced in 2015 into the care of patients at risk of PIH in Ziekenhuis Oost-Limburg (Genk, Belgium) to improve both maternal and neonatal outcomes. In developing new strategies for obstetric care in pregnant women, including RM, it is important to understand the psychosocial characteristics associated with adherence to RM to optimize care.

Objective: The aim of this study was to explore the role of patients' psychosocial characteristics (severity of depression or anxiety, cognitive factors, attachment styles, and personality traits) in their adherence to RM.

Methods: Questionnaires were sent by email to 108 mothers the day after they entered an RM program for pregnant women at risk of PIH. The Generalized Anxiety Disorder Assessment-7 and Patient Health Questionnaire-9 (PHQ-9) were used to assess anxiety and the severity of depression, respectively; an adaptation of the Pain Catastrophizing Scale was used to assess cognitive factors; and attachment and personality were measured with the Experiences in Close Relationships-Revised Scale (ECR-R), the Depressive Experiences Questionnaire, and the Multidimensional Perfectionism Scale, respectively.

Results: The moderate adherence group showed significantly higher levels of anxiety and depression, negative cognitions, and insecure attachment styles, especially compared with the over adherence group. The low adherence group scored significantly higher than the other groups on other-oriented perfectionism. There were no significant differences between the good and over adherence groups. Single linear regression showed that the answers on the PHQ-9 and ECR-R questionnaires were significantly related to the adherence rate.

Conclusions: This study demonstrates the relationships between adherence to RM and patient characteristics in women at risk of PIH. Alertness toward the group of women who show less than optimal adherence is essential. These findings call for further research on the management of PIH and the importance of individual tailoring of RM in this patient group.

Trial registration: ClinicalTrials.gov NCT03509272; https://ichgcp.net/clinical-trials-registry/NCT03509272.

Keywords: gestational hypertensive diseases; hypertension, pregnancy-induced; monitoring, ambulatory; remote monitoring; surveys and questionnaires; treatment adherence and compliance.

Conflict of interest statement

Conflicts of Interest: None declared.

©Thijs Vandenberk, Dorien Lanssens, Valerie Storms, Inge M Thijs, Lotte Bamelis, Lars Grieten, Wilfried Gyselaers, Eileen Tang, Patrick Luyten. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 28.08.2019.

References

    1. Kintiraki E, Papakatsika S, Kotronis G, Goulis DG, Kotsis V. Pregnancy-induced hypertension. Hormones (Athens) 2015;14(2):211–23. doi: 10.14310/horm.2002.1582.
    1. Ayala DE, Hermida RC. Ambulatory blood pressure monitoring for the early identification of hypertension in pregnancy. Chronobiol Int. 2013 Mar;30(1-2):233–59. doi: 10.3109/07420528.2012.714687.
    1. Kattah AG, Garovic VD. The management of hypertension in pregnancy. Adv Chronic Kidney Dis. 2013 May;20(3):229–39. doi: 10.1053/j.ackd.2013.01.014.
    1. Odibo IN, Wendel PJ, Magann EF. Telemedicine in obstetrics. Clin Obstet Gynecol. 2013 Sep;56(3):422–33. doi: 10.1097/GRF.0b013e318290fef0.
    1. Cruz JB, Brooks D, Marques A. Home telemonitoring in COPD: a systematic review of methodologies and patients' adherence. Int J Med Inform. 2014 Apr;83(4):249–63. doi: 10.1016/j.ijmedinf.2014.01.008.
    1. Lanssens D, Vandenberk T, Smeets CJ, De Cannière H, Molenberghs G, Van Moerbeke A, van den Hoogen A, Robijns T, Vonck S, Staelens A, Storms V, Thijs IM, Grieten L, Gyselaers W. Remote monitoring of hypertension diseases in pregnancy: a pilot study. JMIR Mhealth Uhealth. 2017 Mar 09;5(3):e25. doi: 10.2196/mhealth.6552.
    1. Ganapathy RG, Grewal A, Castleman JS. Remote monitoring of blood pressure to reduce the risk of preeclampsia related complications with an innovative use of mobile technology. Pregnancy Hypertens. 2016 Oct;6(4):263–5. doi: 10.1016/j.preghy.2016.04.005.
    1. Rhoads S, Serrano CI, Lynch CE, Ounpraseuth ST, Gauss CH, Payakachat N, Lowery CL, Eswaran H. Exploring implementation of m-Health monitoring in postpartum women with hypertension. Telemed J E Health. 2017 Dec;23(10):833–841. doi: 10.1089/tmj.2016.0272.
    1. Toogood PA, Abdel MP, Spear JA, Cook SM, Cook DJ, Taunton MJ. The monitoring of activity at home after total hip arthroplasty. Bone Joint J. 2016 Nov;98-B(11):1450–4. doi: 10.1302/0301-620X.98B11.BJJ-2016-0194.R1.
    1. Law LE, Edirisinghe N, Wason JM. Use of an embedded, micro-randomised trial to investigate non-compliance in telehealth interventions. Clin Trials. 2016 Dec;13(4):417–24. doi: 10.1177/1740774516637075.
    1. Lyngå P, Fridlund B, Langius-Eklöf A, Bohm K. Perceptions of transmission of body weight and telemonitoring in patients with heart failure? Int J Qual Stud Health Well-being. 2013 Dec 16;8:21524. doi: 10.3402/qhw.v8i0.21524.
    1. Souza W, Jardim PC, Brito LP, Araújo FA, Sousa AL. Self measurement of blood pressure for control of blood pressure levels and adherence to treatment. Arq Bras Cardiol. 2012 Feb;98(2):167–74.
    1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 04;353(5):487–97. doi: 10.1056/NEJMra050100.
    1. Erdine S, Arslan E. Monitoring treatment adherence in hypertension. Curr Hypertens Rep. 2013 Aug;15(4):269–72. doi: 10.1007/s11906-013-0369-9.
    1. Slade AC, Cohen LJ, Sadler LS, Miller M. The psychology and psychopathology of pregnancy: reorganization and transformation. In: Zeanah CH, editor. Handbook of Infant Mental Health, Third Edition. New York: The Guilford Press; 2009. pp. 22–39.
    1. Black KD. Stress, symptoms, self-monitoring confidence, well-being, and social support in the progression of preeclampsia/gestational hypertension. J Obstet Gynecol Neonatal Nurs. 2007;36(5):10.
    1. Leeners B, Stiller R, Neumaier-Wagner P, Kuse S, Schmitt A, Rath W. Psychosocial distress associated with treatment of hypertensive diseases in pregnancy. Psychosomatics. 2008;49(5):413–9. doi: 10.1176/appi.psy.49.5.413.
    1. Karsnitz D, Ward S. Spectrum of anxiety disorders: diagnosis and pharmacologic treatment. J Midwifery Womens Health. 2011;56(3):266–81. doi: 10.1111/j.1542-2011.2011.00045.x.
    1. Weisberg R, Paquette JA. Screening and treatment of anxiety disorders in pregnant and lactating women. Womens Health Issues. 2002;12(1):32–6.
    1. Sutter-Dallay A, Giaconne-Marcesche V, Glatigny-Dallay E, Verdoux H. Women with anxiety disorders during pregnancy are at increased risk of intense postnatal depressive symptoms: a prospective survey of the MATQUID cohort. Eur Psychiatry. 2004 Dec;19(8):459–63. doi: 10.1016/j.eurpsy.2004.09.025.
    1. Mikulincer M, Shaver PR. Attachment, group-related processes, and psychotherapy. Int J Group Psychother. 2007 Apr;57(2):233–45. doi: 10.1521/ijgp.2007.57.2.233.
    1. Bornstein R, Languirand FM. Healthy Dependency: Leaning on Others Without Losing Yourself. New York: William Morrow; 2003.
    1. Ciechanowski P, Sullivan M, Jensen M, Romano J, Summers H. The relationship of attachment style to depression, catastrophizing and health care utilization in patients with chronic pain. Pain. 2003 Aug;104(3):627–37.
    1. Ciechanowski PS, Walker EA, Katon WJ, Russo JE. Attachment theory: a model for health care utilization and somatization. Psychosom Med. 2002;64(4):660–7.
    1. Hewitt P, Flett GL, Turnbull-Donovan W, Mikail Sf. The multidimensional perfectionism scale: reliability, validity, and psychometric properties in psychiatric samples. Psychol Assess. 1991 Sep;3(3):464–468. doi: 10.1037/1040-3590.3.3.464.
    1. Lanssens D, Vonck S, Storms V, Thijs IM, Grieten L, Gyselaers W. The impact of a remote monitoring program on the prenatal follow-up of women with gestational hypertensive disorders. Eur J Obstet Gynecol Reprod Biol. 2018 Apr;223:72–78. doi: 10.1016/j.ejogrb.2018.02.015.
    1. Lanssens DV, Vandenberk T, Smeets CJ, De Cannière H, Vonck S, Claessens J, Heyrman Y, Vandijck D, Storms V, Thijs IM, Grieten L, Gyselaers W. Prenatal remote monitoring of women with gestational hypertensive diseases: cost analysis. J Med Internet Res. 2018 Dec 26;20(3):e102. doi: 10.2196/jmir.9552.
    1. Mayes L, Leckman JF. Parental representations and subclinical changes in postpartum mood. Infant Ment Health J. 2007 May;28(3):281–95. doi: 10.1002/imhj.20136.
    1. Sidebottom AC, Harrison PA, Godecker A, Kim H. Validation of the Patient Health Questionnaire (PHQ)-9 for prenatal depression screening. Arch Womens Ment Health. 2012 Oct;15(5):367–74. doi: 10.1007/s00737-012-0295-x.
    1. Yonkers K, Smith MV, Gotman N, Belanger K. Typical somatic symptoms of pregnancy and their impact on a diagnosis of major depressive disorder. Gen Hosp Psychiatry. 2009;31(4):327–33. doi: 10.1016/j.genhosppsych.2009.03.005.
    1. Port K, Palm K, Viigimaa M. Daily usage and efficiency of remote home monitoring in hypertensive patients over a one-year period. J Telemed Telecare. 2005;11(Suppl 1):34–6. doi: 10.1258/1357633054461705.
    1. Celler B, Argha A, Varnfield M, Jayasena R. Patient adherence to scheduled vital sign measurements during home telemonitoring: analysis of the intervention arm in a before and after trial. JMIR Med Inform. 2018 Apr 09;6(2):e15. doi: 10.2196/medinform.9200.
    1. Maeder A, Poultney N, Morgan G, Lippiatt R. Patient compliance in home-based self-care telehealth projects. J Telemed Telecare. 2015 Dec;21(8):439–42. doi: 10.1177/1357633X15612382.
    1. Jonassaint C, Shah N, Jonassaint J, De Castro L. Usability and feasibility of an mHealth intervention for monitoring and managing pain symptoms in sickle cell disease: the sickle cell disease mobile application to record symptoms via technology (SMART) Hemoglobin. 2015;39(3):162–8. doi: 10.3109/03630269.2015.1025141.
    1. Bai G, Raat H, Jaddoe VW, Mautner E, Korfage IJ. Trajectories and predictors of women's health-related quality of life during pregnancy: a large longitudinal cohort study. PLoS One. 2018;13(4):e0194999. doi: 10.1371/journal.pone.0194999.
    1. Biaggi A, Conroy S, Pawlby S, Pariante CM. Identifying the women at risk of antenatal anxiety and depression: a systematic review. J Affect Disord. 2016 Feb;191:62–77. doi: 10.1016/j.jad.2015.11.014.
    1. Ballard C, Davis R, Cullen PC, Mohan RN, Dean C. Prevalence of postnatal psychiatric morbidity in mothers and fathers. Br J Psychiatry. 1994 Jun;164(6):782–8.
    1. Simpson W, Glazer M, Michalski N, Steiner M, Frey BN. Comparative efficacy of the generalized anxiety disorder 7-item scale and the Edinburgh Postnatal Depression Scale as screening tools for generalized anxiety disorder in pregnancy and the postpartum period. Can J Psychiatry. 2014 Aug;59(8):434–40. doi: 10.1177/070674371405900806.
    1. Austin MP. Antenatal screening and early intervention for "perinatal" distress, depression and anxiety: where to from here? Arch Womens Ment Health. 2004 Feb;7(1):1–6. doi: 10.1007/s00737-003-0034-4.
    1. Zhong Q, Gelaye B, Zaslavsky AM, Fann JR, Rondon MB, Sánchez SE, Williams MA. Diagnostic validity of the Generalized Anxiety Disorder-7 (GAD-7) among pregnant women. PLoS One. 2015;10(4):e0125096. doi: 10.1371/journal.pone.0125096.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir